1
/
of
0
FDA Drug Approval, N009495, MAREZINE
FDA Drug Approval, N009495, MAREZINE
Regular price
$49.00 USD
Regular price
Sale price
$49.00 USD
Unit price
/
per
NDA: 009495
Company: GLAXOSMITHKLINE
Drug Name: MAREZINE
Active Ingredients: CYCLIZINE LACTATE
Strength: 50MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/24/1954
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Company: GLAXOSMITHKLINE
Drug Name: MAREZINE
Active Ingredients: CYCLIZINE LACTATE
Strength: 50MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/24/1954
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details